Heart Disease Clinical Trials in Chicago

Showing 321-340 of 440 trials

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients

NCT00573560

The CardioKinetix Ventricular Partitioning Device (VPD) is intended to isolate the malfunctioning portion of the left ventricle in patients with symptoms of heart failure due to ischemic heart disease. By isolating the malfunctioning portion of the left ventricle, it is hypothesized that the left ventricle will pump more effectively.

Heart Failure

CardioKinetix, Inc20 participantsStarted Dec 2007

Washington D.C., District of Columbia, United States • Chicago, Illinois, United States • Asheville, North Carolina, United States +4 more locations

COMPLETEDNA2.2 miles

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

NCT00378950

Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. This study will evaluate the effectiveness of an educational program developed for various levels of health literacy at improving medical outcomes and quality of life in individuals with HF.

Heart Failure, Congestive

University of North Carolina, Chapel Hill605 participantsStarted Mar 2007

Los Angeles, California, United States • San Francisco, California, United States • Chicago, Illinois, United States +1 more locations

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Heart Disease Trials in Other Cities

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Naltrexone/Bupropion Cardiovascular Outcomes Study

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

The Congestive Heart Failure Adherence Redesign Trial

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Niacin Plus Statin to Prevent Vascular Events

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

Evaluation of Vepoloxamer in Chronic Heart Failure

Sensor Optimization of Cardiac Resynchronization Therapy Response

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Other Conditions in Chicago